40 results
8-K
EX-99.2
HROW
Harrow Inc
19 Mar 24
Harrow Announces Fourth Quarter and Year-End 2023 Financial Results
5:26pm
the ability of IHEEZO to reduce opioid use and intraoperative pain during cataract surgery. The SPARE Study is expected to last just under a year … Pharmaceuticals, (2) Eton Pharmaceuticals, and (3) Surface Ophthalmics.
Founded by Harrow in 2018, Melt Pharmaceuticals is developing a non-IV and non-opioid
8-K
EX-99
HROW
Harrow Inc
3 Jan 24
Melt Pharmaceuticals Provides Corporate Update
8:00am
, a non-IV, non-opioid tablet that combines fixed doses of midazolam (3mg) and ketamine (50mg), is administered sublingually using Catalent Inc.’s … -opioid MELT-300 product candidate, which we believe has the potential to revolutionize short-duration procedural sedation for more than 100 million U.S
8-K
EX-99.2
HROW
Harrow Inc
13 Nov 23
Harrow Announces Third Quarter 2023 Financial Results
4:34pm
Pharmaceuticals, and (3) Surface Ophthalmics.
Founded by Harrow in 2018, Melt Pharmaceuticals is developing a non-IV and non-opioid sedation platform
8-K
EX-99.2
HROW
Harrow Inc
9 Aug 23
Harrow Announces Second Quarter 2023 Financial Results
4:05pm
help address the opioid crisis in our country, and we have been thrilled to hear from several surgeons that, with IHEEZO, as was the case in the IHEEZO … clinical studies, they, too, were able to eliminate opioid use from most of their cataract surgeries. If we can make even a small impact
424B5
gipguuef r30r6
19 Jul 23
Prospectus supplement for primary offering
5:19pm
424B5
pof 9djeom58rbgd3
18 Jul 23
Prospectus supplement for primary offering
5:03pm
424B5
hrrrqjwf1656lluzqyh
19 Dec 22
Prospectus supplement for primary offering
4:50pm
424B5
thpoj1jyrf1y14q
14 Dec 22
Prospectus supplement for primary offering
5:29pm
424B5
c9p m5wxxwttn67bu2c7
14 Dec 22
Prospectus supplement for primary offering
6:44am
8-K
EX-99.2
vov1ru5
14 Nov 22
Harrow Announces Third Quarter 2022 Financial Results
4:20pm
8-K
EX-99.2
38p n21lfyrm
5 May 22
Harrow Health Announces First Quarter 2022 Financial Results
12:00am
8-K
EX-99.2
y4xs80r
10 Mar 22
Harrow Health Announces Fourth Quarter and Year-End 2021 Financial Results
4:30pm
8-K
EX-99.1
me2tnhh56r
2 Sep 21
Entry into a Material Definitive Agreement
4:15pm